-
1
-
-
33748749890
-
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
-
DOI 10.1093/annonc/mdl137
-
M.S. Aapro, S.M. Grunberg, G.M. Manikhas, G. Olivares, T. Suarez, S.A. Tjulandin, L.F. Bertoli, F. Yunus, B. Morrica, F. Lordick, and A. Macciocchi A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy Ann. Oncol. 17 2006 1441 1449 (Pubitemid 44400384)
-
(2006)
Annals of Oncology
, vol.17
, Issue.9
, pp. 1441-1449
-
-
Aapro, M.S.1
Grunberg, S.M.2
Manikhas, G.M.3
Olivares, G.4
Suarez, T.5
Tjulandin, S.A.6
Bertoli, L.F.7
Yunus, F.8
Morrica, B.9
Lordick, F.10
Macciocchi, A.11
-
2
-
-
80755126820
-
Antiemetics: American society of clinical oncology clinical practice guideline update
-
E. Basch, A.A. Prestrud, P.J. Hesketh, M.G. Kris, P.C. Feyer, M.R. Somerfield, M. Chesney, R.A. Clark-Snow, A.M. Flaherty, B. Freundlich, G. Morrow, K.V. Rao, R.N. Schwartz, and G.H. Lyman Antiemetics: American society of clinical oncology clinical practice guideline update J. Clin. Oncol. 29 2011 4189 4198
-
(2011)
J. Clin. Oncol.
, vol.29
, pp. 4189-4198
-
-
Basch, E.1
Prestrud, A.A.2
Hesketh, P.J.3
Kris, M.G.4
Feyer, P.C.5
Somerfield, M.R.6
Chesney, M.7
Clark-Snow, R.A.8
Flaherty, A.M.9
Freundlich, B.10
Morrow, G.11
Rao, K.V.12
Schwartz, R.N.13
Lyman, G.H.14
-
3
-
-
0014899702
-
Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs
-
C. Bianchi, L. Beani, and C. Crema Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs Eur. J. Pharmacol. 12 1970 332 341
-
(1970)
Eur. J. Pharmacol.
, vol.12
, pp. 332-341
-
-
Bianchi, C.1
Beani, L.2
Crema, C.3
-
4
-
-
4644282710
-
3 receptor antagonists for prevention of late acute-onset emesis
-
DOI 10.1345/aph.1D191
-
M. Constenla 5-HT3 receptor antagonists for prevention of late acute-onset emesis Ann. Pharmacother. 38 2004 1683 1691 (Pubitemid 39297769)
-
(2004)
Annals of Pharmacotherapy
, vol.38
, Issue.10
, pp. 1683-1691
-
-
Constenla, M.1
-
5
-
-
67650685575
-
Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting
-
N.A. Darmani, and A.P. Ray Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting Chem. Rev. 109 2009 3158 3199
-
(2009)
Chem. Rev.
, vol.109
, pp. 3158-3199
-
-
Darmani, N.A.1
Ray, A.P.2
-
6
-
-
79959685144
-
Synergistic antiemetic interactions between serotonergic 5-HT(3) and tachykininergic NK(1)-receptor antagonists in the least shrew (Cryptotis parva)
-
N.A. Darmani, S. Chebolu, B. Amos, and T. Alkam Synergistic antiemetic interactions between serotonergic 5-HT(3) and tachykininergic NK(1)-receptor antagonists in the least shrew (Cryptotis parva) Pharmacol. Biochem. Behav. 99 2011 573 579
-
(2011)
Pharmacol. Biochem. Behav.
, vol.99
, pp. 573-579
-
-
Darmani, N.A.1
Chebolu, S.2
Amos, B.3
Alkam, T.4
-
7
-
-
0034548637
-
Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: Results of a meta-analysis of randomized controlled trials
-
A. del Giglio, H.P. Soares, C. Caparroz, and P.C. Castro Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting: results of a meta-analysis of randomized controlled trials Cancer 89 2000 2301 2308
-
(2000)
Cancer
, vol.89
, pp. 2301-2308
-
-
Del Giglio, A.1
Soares, H.P.2
Caparroz, C.3
Castro, P.C.4
-
8
-
-
0344412945
-
3 Receptor Antagonist: Results of a Phase III, Single-Dose Trial Versus Dolasetron
-
DOI 10.1002/cncr.11817
-
P. Eisenberg, J. Figueroa-Vadillo, R. Zamora, V. Charu, J. Hajdenberg, A. Cartmell, A. Macciocchi, and S. Grunberg Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron Cancer 98 2003 2473 2482 (Pubitemid 37466663)
-
(2003)
Cancer
, vol.98
, Issue.11
, pp. 2473-2482
-
-
Eisenberg, P.1
Figueroa-Vadillo, J.2
Zamora, R.3
Charu, V.4
Hajdenberg, J.5
Cartmell, A.6
Macciocchi, A.7
Grunberg, S.8
-
10
-
-
34247516968
-
-
NCCN.org
-
Ettinger, D.S., Armstrong, D.K., Barbour, S., Berger, M.J., Bradbury, P.J.B., Ellis, B., Kirkegaard, G., Kloth, S., Kris, D.D., Lim, M.G., Boehnke, D., Michaud, L., Nabati, L., Noonan, K., Rugo, H.S., Siler, D., Sorscher, S.M., Stelts, S., Stucky-Marshall, L., Todaro, B., Urba, S., 2011. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) Antiemesis. version 1.2012. NCCN.org.
-
(2011)
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) Antiemesis. Version 1.2012
-
-
Ettinger, D.S.1
Armstrong, D.K.2
Barbour, S.3
Berger, M.J.4
Bradbury, P.J.B.5
Ellis, B.6
Kirkegaard, G.7
Kloth, S.8
Kris, D.D.9
Lim, M.G.10
Boehnke, D.11
Michaud, L.12
Nabati, L.13
Noonan, K.14
Rugo, H.S.15
Siler, D.16
Sorscher, S.M.17
Stelts, S.18
Stucky-Marshall, L.19
Todaro, B.20
Urba, S.21
more..
-
11
-
-
78650375895
-
Update and new trends in antiemetic therapy: The continuing need for novel therapies
-
Feyer, P., Jordan, K., 2011. Update and new trends in antiemetic therapy: the continuing need for novel therapies. Ann. Oncol. 22, 30-38.
-
(2011)
Ann. Oncol.
, vol.22
, pp. 30-38
-
-
Feyer, P.1
Jordan, K.2
-
12
-
-
0015862080
-
Pharmacological analysis of the effects of metoclopramide on the guinea-pig ileum in vitro
-
Fontaine, J., Reuse, J.J., 1973. Pharmacological analysis of the effects of metoclopramide on the guinea-pig ileum in vitro. Arch. Int. Pharmacodyn. Ther. 204, 293-305.
-
(1973)
Arch. Int. Pharmacodyn. Ther.
, vol.204
, pp. 293-305
-
-
Fontaine, J.1
Reuse, J.J.2
-
13
-
-
33745900269
-
3 Receptor Internalization in Enteric Neurons in Rat Ileum
-
DOI 10.1053/j.gastro.2006.04.013, PII S0016508506007529
-
Freeman, S.L., Glatzle, J., Robin, C.S., Valdellon, M., Sternini, C., Sharp, J.W., Raybould, H.E., 2006. Ligand-induced 5-HT3 receptor internalization in enteric neurons in rat ileum. Gastroenterology 131, 97-107. (Pubitemid 44040915)
-
(2006)
Gastroenterology
, vol.131
, Issue.1
, pp. 97-107
-
-
Freeman, S.L.1
Glatzle, J.2
Robin, C.S.3
Valdellon, M.4
Sternini, C.5
Sharp, J.W.6
Raybould, H.E.7
-
14
-
-
14544288652
-
Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications
-
DOI 10.1200/JCO.2005.04.022
-
Geling, O., Eichler, H.G., 2005. Should 5-hydroxytryptamine-3 receptor antagonists be administered beyond 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications. J. Clin. Oncol. 23, 1289-1294. (Pubitemid 46202287)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.6
, pp. 1289-1294
-
-
Geling, O.1
Eichler, H.-G.2
-
15
-
-
10744219621
-
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: Results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
-
DOI 10.1093/annonc/mdg417
-
Gralla, R., Lichinitser, M., Van Der Vegt, S., Sleeboom, H., Mezger, J., Peschel, C., Tonini, G., Labianca, R., Macciocchi, A., Aapro, M., 2003. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann. Oncol. 14, 1570-1577. (Pubitemid 37304615)
-
(2003)
Annals of Oncology
, vol.14
, Issue.10
, pp. 1570-1577
-
-
Gralla, R.1
Lichinitser, M.2
Van Der Vegt, S.3
Sleeboom, H.4
Mezger, J.5
Peschel, C.6
Tonini, G.7
Labianca, R.8
Macciocchi, A.9
Aapro, M.10
-
16
-
-
0027366610
-
Control of chemotherapy-induced emesis
-
DOI 10.1056/NEJM199312093292408
-
Grunberg, S.M., Hesketh, P.J., 1993. Control of chemotherapy-induced emesis. N. Engl. J. Med. 329, 1790-1796. (Pubitemid 23355554)
-
(1993)
New England Journal of Medicine
, vol.329
, Issue.24
, pp. 1790-1796
-
-
Grunberg, S.M.1
Hesketh, P.J.2
-
17
-
-
0018849228
-
125I-epidermal growth factor in BALB 3T3 cells
-
Haigler, H.T., Maxfield, F.R., Willingham, M.C., Pastan, I., 1980. Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. J. Biol. Chem. 255, 1239-1241. (Pubitemid 10111980)
-
(1980)
Journal of Biological Chemistry
, vol.255
, Issue.4
, pp. 1239-1241
-
-
Haigler, H.T.1
Maxfield, F.R.2
Willingham, M.C.3
Pastan, I.4
-
18
-
-
84860834497
-
Substance P antagonists
-
Hesketh, P.J. (Ed.) Jones and Bartlett Publishers, Inc., London
-
Herrstedt, J., 2005. Substance P antagonists. In: Hesketh, P.J. (Ed.),Management of Nausea and Vomiting in Cancer and Cancer Treatment. Jones and Bartlett Publishers, Inc., London, pp. 211-230.
-
(2005)
Management of Nausea and Vomiting in Cancer and Cancer Treatment
, pp. 211-230
-
-
Herrstedt, J.1
-
19
-
-
0038185163
-
Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
-
DOI 10.1016/S0959-8049(02)00674-3
-
Hesketh, P.J., Van Belle, S., Aapro, M., Tattersall, F.D., Naylor, R.J., Hargreaves, R., Carides, A.D., Evans, J.K., Horgan, K.J., 2003. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur. J. Cancer 39, 1074-1080. (Pubitemid 36555864)
-
(2003)
European Journal of Cancer
, vol.39
, Issue.8
, pp. 1074-1080
-
-
Hesketh, P.J.1
Van Belle, S.2
Aapro, M.3
Tattersall, F.D.4
Naylor, R.J.5
Hargreaves, R.6
Carides, A.D.7
Evans, J.K.8
Horgan, K.J.9
-
20
-
-
0024477741
-
3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret
-
Higgins, G.A., Kilpatrick, G.J., Bunce, K.T., Jones, B.J., Tyers, M.B., 1989. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br. J. Pharmacol. 97, 247-255. (Pubitemid 19113970)
-
(1989)
British Journal of Pharmacology
, vol.97
, Issue.1
, pp. 247-255
-
-
Higgins, G.A.1
Kilpatrick, G.J.2
Bunce, K.T.3
Jones, B.J.4
Tyers, M.B.5
-
21
-
-
0035803984
-
Central neurocircuitry associated with emesis
-
PII S000293430100849X
-
Hornby, P.J., 2001. Central neurocircuitry associated with emesis. Am. J. Med. 111 (Suppl. 8A), 106S-112S. (Pubitemid 34032001)
-
(2001)
American Journal of Medicine
, vol.111
, Issue.8 SUPPL. 1
-
-
Hornby, P.J.1
-
22
-
-
3042857727
-
Substance P potentiates 5-HT3 receptor-mediated current in rat trigeminal ganglion neurons
-
Hu, W.P., You, X.H., Guan, B.C., Ru, L.Q., Chen, J.G., Li, Z.W., 2004. Substance P potentiates 5-HT3 receptor-mediated current in rat trigeminal ganglion neurons. Neurosci. Lett. 365, 147-152.
-
(2004)
Neurosci. Lett.
, vol.365
, pp. 147-152
-
-
Hu, W.P.1
You, X.H.2
Guan, B.C.3
Ru, L.Q.4
Chen, J.G.5
Li, Z.W.6
-
23
-
-
33846088469
-
Comparative activity of antiemetic drugs
-
DOI 10.1016/j.critrevonc.2006.08.003, PII S1040842806001661
-
Jordan, K., Schmoll, H.J., Aapro, M.S., 2007. Comparative activity of antiemetic drugs. Crit. Rev. Oncol. Hematol. 61, 162-175. (Pubitemid 46073781)
-
(2007)
Critical Reviews in Oncology/Hematology
, vol.61
, Issue.2
, pp. 162-175
-
-
Jordan, K.1
Schmoll, H.J.2
Aapro, M.S.3
-
25
-
-
0033695663
-
Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization
-
Lin, J.W., Ju, W., Foster, K., Lee, S.H., Ahmadian, G., Wyszynski, M., Wang, Y.T., Sheng, M., 2000. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat. Neurosci. 3, 1282-1290.
-
(2000)
Nat. Neurosci.
, vol.3
, pp. 1282-1290
-
-
Lin, J.W.1
Ju, W.2
Foster, K.3
Lee, S.H.4
Ahmadian, G.5
Wyszynski, M.6
Wang, Y.T.7
Sheng, M.8
-
26
-
-
0035812617
-
3 receptors
-
DOI 10.1016/S0014-2999(01)01297-3, PII S0014299901012973
-
Minami, M., Endo, T., Yokota, H., Ogawa, T., Nemoto, M., Hamaue, N., Hirafuji, M., Yoshioka, M., Nagahisa, A., Andrews, P.L., 2001. Effects of CP-99, 994, a tachykinin NK(1) receptor antagonist, on abdominal afferent vagal activity in ferrets: evidence for involvement of NK(1) and 5-HT(3) receptors. Eur. J. Pharmacol. 428, 215-220. (Pubitemid 33000143)
-
(2001)
European Journal of Pharmacology
, vol.428
, Issue.2
, pp. 215-220
-
-
Minami, M.1
Endo, T.2
Yokota, H.3
Ogawa, T.4
Nemoto, M.5
Hamaue, N.6
Hirafuji, M.7
Yoshioka, M.8
Nagahisa, A.9
Andrews, P.L.R.10
-
27
-
-
0022481464
-
Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism
-
Miner, W.D., Sanger, G.J., 1986. Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br. J. Pharmacol. 88, 497-499. (Pubitemid 16066912)
-
(1986)
British Journal of Pharmacology
, vol.88
, Issue.3
, pp. 497-499
-
-
Miner, W.D.1
Sanger, G.J.2
-
28
-
-
0037664644
-
1 receptors in HEK293 cells
-
DOI 10.1038/sj.bjp.0705306
-
Pheng, L.H., Dumont, Y., Fournier, A., Chabot, J.G., Beaudet, A., Quirion, R., 2003. Agonistand antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br. J. Pharmacol. 139, 695-704. (Pubitemid 36819596)
-
(2003)
British Journal of Pharmacology
, vol.139
, Issue.4
, pp. 695-704
-
-
Pheng, L.H.1
Dumont, Y.2
Fournier, A.3
Chabot, J.-G.4
Beaudet, A.5
Quirion, R.6
-
29
-
-
0024499430
-
Substance P and serotonin act synergistically to activate a cation permeability in a neuronal cell line
-
DOI 10.1016/0006-8993(89)91333-4
-
Reiser, G., Hamprecht, B., 1989. Substance P and serotonin act synergistically to activate a cation permeability in a neuronal cell line. Brain Res. 479, 40-48. (Pubitemid 19030911)
-
(1989)
Brain Research
, vol.479
, Issue.1
, pp. 40-48
-
-
Reiser, G.1
Hamprecht, B.2
-
30
-
-
0030993594
-
Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor
-
Roettger, B.F., Ghanekar, D., Rao, R., Toledo, C., Yingling, J., Pinon, D., Miller, L.J., 1997. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol. Pharmacol. 51, 357-362. (Pubitemid 27118469)
-
(1997)
Molecular Pharmacology
, vol.51
, Issue.3
, pp. 357-362
-
-
Roettger, B.F.1
Ghanekar, D.2
Rao, R.3
Toledo, C.4
Yingling, J.5
Pinon, D.6
Miller, L.J.7
-
31
-
-
77954319603
-
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Results of the Perugia consensus conference
-
Roila, F., Herrstedt, J., Aapro,M., Gralla, R.J., Einhorn, L.H., Ballatori, E., Bria, E., Clark-Snow, R.A., Espersen, B.T., Feyer, P., Grunberg, S.M., Hesketh, P.J., Jordan, K., Kris, M.G., Maranzano, E., Molassiotis, A., Morrow, G., Olver, I., Rapoport, B.L., Rittenberg, C., Saito, M., Tonato, M., Warr, D., 2010. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann. Oncol. 21 (Suppl. 5), v232-v243.
-
(2010)
Ann. Oncol.
, vol.21
, Issue.SUPPL. 5
-
-
Roila, F.1
Herrstedt, J.2
Aapro, M.3
Gralla, R.J.4
Einhorn, L.H.5
Ballatori, E.6
Bria, E.7
Clark-Snow, R.A.8
Espersen, B.T.9
Feyer, P.10
Grunberg, S.M.11
Hesketh, P.J.12
Jordan, K.13
Kris, M.G.14
Maranzano, E.15
Molassiotis, A.16
Morrow, G.17
Olver, I.18
Rapoport, B.L.19
Rittenberg, C.20
Saito, M.21
Tonato, M.22
Warr, D.23
more..
-
32
-
-
49949093837
-
Palonosetron exhibits uniquemolecular interactions with the 5-HT3 receptor
-
Rojas, C., Stathis, M., Thomas, A.G.,Massuda, E.B.,Alt, J., Zhang, J., Rubenstein, E., Sebastiani, S., Cantoreggi, S., Snyder, S.H., Slusher, B., 2008. Palonosetron exhibits uniquemolecular interactions with the 5-HT3 receptor. Anesth. Analg. 107, 469-478.
-
(2008)
Anesth. Analg.
, vol.107
, pp. 469-478
-
-
Rojas, C.1
Stathis, M.2
Thomas, A.G.3
Massuda, E.B.4
Alt, J.5
Zhang, J.6
Rubenstein, E.7
Sebastiani, S.8
Cantoreggi, S.9
Snyder, S.H.10
Slusher, B.11
-
33
-
-
78149276261
-
The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo
-
Rojas, C., Li, Y., Zhang, J., Stathis, M., Alt, J., Thomas, A.G., Cantoreggi, S., Sebastiani, S., Pietra, C., Slusher, B.S., 2010a. The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo. J. Pharmacol. Exp. Ther. 335, 362-368.
-
(2010)
J. Pharmacol. Exp. Ther.
, vol.335
, pp. 362-368
-
-
Rojas, C.1
Li, Y.2
Zhang, J.3
Stathis, M.4
Alt, J.5
Thomas, A.G.6
Cantoreggi, S.7
Sebastiani, S.8
Pietra, C.9
Slusher, B.S.10
-
34
-
-
70649090118
-
Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function
-
Rojas, C., Thomas, A.G., Alt, J., Stathis, M., Zhang, J., Rubenstein, E.B., Sebastiani, S., Cantoreggi, S., Slusher, B.S., 2010b. Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function. Eur. J. Pharmacol. 626, 193-199.
-
(2010)
Eur. J. Pharmacol.
, vol.626
, pp. 193-199
-
-
Rojas, C.1
Thomas, A.G.2
Alt, J.3
Stathis, M.4
Zhang, J.5
Rubenstein, E.B.6
Sebastiani, S.7
Cantoreggi, S.8
Slusher, B.S.9
-
35
-
-
84860838090
-
-
Society for Neuroscience,Washington, DC ProgramNo. 341.02, PosterNo. D/35 2011
-
Rojas, C., Stathis, M., Cantoreggi, S., Pietra, C., Slusher, B., 2011. Netupitant Inhibition of Substance-P Mediated Responses in NG108-15 Cells is Enhanced by Palonosetron. Society for Neuroscience,Washington, DC. 2011. ProgramNo. 341.02, PosterNo. D/35.
-
(2011)
Netupitant Inhibition of Substance-P Mediated Responses in NG108-15 Cells Is Enhanced by Palonosetron
-
-
Rojas, C.1
Stathis, M.2
Cantoreggi, S.3
Pietra, C.4
Slusher, B.5
-
36
-
-
33749857161
-
New approaches to chemotherapy-induced nausea and vomiting: From neuropharmacology to clinical investigations
-
Rubenstein, E.B., Slusher, B.S., Rojas, C., Navari, R.M., 2006. New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations. Cancer J. 12, 341-347. (Pubitemid 44564817)
-
(2006)
Cancer Journal
, vol.12
, Issue.5
, pp. 341-347
-
-
Rubenstein, E.B.1
Slusher, B.S.2
Rojas, C.3
Navari, R.M.4
-
37
-
-
27944502233
-
Mechanisms of acute, delayed and anticipatory emesis induced by anticancer therapies
-
Hesketh, P.J. (Ed.) Jones and Bartlett Publishers, Inc., London
-
Rudd, J.A., Andrews, P.L.R., 2005. Mechanisms of acute, delayed and anticipatory emesis induced by anticancer therapies. In: Hesketh, P.J. (Ed.), Management of Nausea and Vomiting in Cancer and Cancer Treatment. Jones and Bartlett Publishers, Inc., London, pp. 15-66.
-
(2005)
Management of Nausea and Vomiting in Cancer and Cancer Treatment
, pp. 15-66
-
-
Rudd, J.A.1
Andrews, P.L.R.2
-
38
-
-
58749100277
-
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: A double-blind, double-dummy, randomised, comparative phase III trial
-
Saito, M., Aogi, K., Sekine, I., Yoshizawa, H., Yanagita, Y., Sakai, H., Inoue, K., Kitagawa, C., Ogura, T., Mitsuhashi, S., 2009. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol. 10, 115-124.
-
(2009)
Lancet Oncol.
, vol.10
, pp. 115-124
-
-
Saito, M.1
Aogi, K.2
Sekine, I.3
Yoshizawa, H.4
Yanagita, Y.5
Sakai, H.6
Inoue, K.7
Kitagawa, C.8
Ogura, T.9
Mitsuhashi, S.10
-
39
-
-
80051773633
-
Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting
-
Schwartzberg, L., Jackson, J., Jain, G., Balu, S., Buchner, D., 2011. Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting. Expert Rev. Pharmacoeconomics Outcomes Res. 11, 481-488.
-
(2011)
Expert Rev. Pharmacoeconomics Outcomes Res.
, vol.11
, pp. 481-488
-
-
Schwartzberg, L.1
Jackson, J.2
Jain, G.3
Balu, S.4
Buchner, D.5
-
40
-
-
0015811131
-
Regulation of acetylcholine receptors in relation to acetylcholinesterase in neuroblastoma cells
-
Simantov, R., Sachs, L., 1973. Regulation of acetylcholine receptors in relation to acetylcholinesterase in neuroblastoma cells. Proc. Natl. Acad. Sci. U. S. A. 70, 2902-2905.
-
(1973)
Proc. Natl. Acad. Sci. U. S. A.
, vol.70
, pp. 2902-2905
-
-
Simantov, R.1
Sachs, L.2
-
41
-
-
1942476106
-
Pharmacokinetic and Safety Evaluation of Palonosetron, a 5-Hydroxytryptamine-3 Receptor Antagonist, in U.S. and Japanese Healthy Subjects
-
DOI 10.1177/0091270004264641
-
Stoltz, R., Cyong, J.C., Shah, A., Parisi, S., 2004. Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects. J. Clin. Pharmacol. 44, 520-531. (Pubitemid 38509721)
-
(2004)
Journal of Clinical Pharmacology
, vol.44
, Issue.5
, pp. 520-531
-
-
Stoltz, R.1
Cyong, J.-C.2
Shah, A.3
Parisi, S.4
-
42
-
-
0030299823
-
1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets
-
DOI 10.1016/S0028-3908(96)00020-2, PII S0028390896000202
-
Tattersall, F.D., Rycroft, W., Francis, B., Pearce, D., Merchant, K., MacLeod, A.M., Ladduwahetty, T., Keown, L., Swain, C., Baker, R., Cascieri, M., Ber, E., Metzger, J., MacIntyre, D.E., Hill, R.G., Hargreaves, R.J., 1996. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 35, 1121-1129. (Pubitemid 27008187)
-
(1996)
Neuropharmacology
, vol.35
, Issue.8
, pp. 1121-1129
-
-
Tattersall, F.D.1
Rycroft, W.2
Francis, B.3
Pearce, D.4
Merchant, K.5
MacLeod, A.M.6
Ladduwahetty, T.7
Keown, L.8
Swain, C.9
Baker, R.10
Cascieri, M.11
Ber, E.12
Metzger, J.13
MacIntyre, D.E.14
Hill, R.G.15
Hargreaves, R.J.16
-
43
-
-
0028944035
-
The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro
-
Wong, E.H., Clark, R., Leung, E., Loury, D., Bonhaus, D.W., Jakeman, L., Parnes, H., Whiting, R.L., Eglen, R.M., 1995. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br. J. Pharmacol. 114, 851-859.
-
(1995)
Br. J. Pharmacol.
, vol.114
, pp. 851-859
-
-
Wong, E.H.1
Clark, R.2
Leung, E.3
Loury, D.4
Bonhaus, D.W.5
Jakeman, L.6
Parnes, H.7
Whiting, R.L.8
Eglen, R.M.9
-
44
-
-
78149246095
-
Upregulation of vagal NK1 receptor by cisplatin facilitates the interaction of substance P and serotoninin the vagal afferent neurons: Implication in the emesis related to chemotherapy
-
Wu, X., Fan, J., Owyang, C., Li, Y., 2009. Upregulation of vagal NK1 receptor by cisplatin facilitates the interaction of substance P and serotoninin the vagal afferent neurons: implication in the emesis related to chemotherapy. Gastroenterology 136, A98-A99 Suppl.
-
(2009)
Gastroenterology
, vol.136
, Issue.SUPPL.
-
-
Wu, X.1
Fan, J.2
Owyang, C.3
Li, Y.4
-
45
-
-
0033605152
-
3 receptor
-
DOI 10.1074/jbc.274.9.5537
-
Yan, D., Schulte, M.K., Bloom, K.E., White, M.M., 1999. Structural features of the ligandbinding domain of the serotonin 5HT3 receptor. J. Biol. Chem. 274, 5537-5541. (Pubitemid 29109202)
-
(1999)
Journal of Biological Chemistry
, vol.274
, Issue.9
, pp. 5537-5541
-
-
Yan, D.1
Schulte, M.K.2
Bloom, K.E.3
White, M.M.4
|